Protean BioDiagnostics Partners with Spesana
PRNewswire – May 9th, 2023
Protean BioDiagnostics partners with Spesana to advance precision medicine at the point of care.
Spesana, a company dedicated to improving patient care with an innovative, point of care precision medicine platform, has announced an agreement with Protean BioDiagnostics. This new agreement will amplify Protean's mission to rapidly deploy innovative and clinically impactful tests. Clinicians are challenged by managing the growing complexity of laboratory testing services, especially in the areas of cancer diagnostics and delivery of precision health.
Protean simplifies the selection and management of patient testing for clinicians with its innovative MAPS™ system. This proprietary system optimizes patient care by efficiently providing and integrating test results, in accordance with continually updated official guidelines, effectively delivering comprehensive decision support, and offering telemedicine-based consultation support.
"Physicians asked for ways to optimize testing on minimal tissue or blood samples. We're excited to partner with Protean BioDiagnostics who can provide enhanced lab services to enable precision medicine for these clinicians," said Carla Balch CEO of Spesana.
As a part of Spesana's Precision Medicine Platform, Protean will be supported by efficient ordering, tracking, and reporting workflows in addition to education and communication capabilities. The result is increased access to Protean's growing list of laboratory diagnostics by clinicians seeking advanced treatment options for their patients.
"We are excited to be working with Spesana to make Protean's innovative MAPS™ system readily available to more clinicians and patients, and to be on the cutting edge of the precision medicine revolution that will positively transform patient care," said Dr Magliocco Protean's Founder and CEO.
For further information, please contact:
Anthony Magliocco MD
CEO & President of Protean BioDiagnostics
Email: info@proteanbiodx.com
Phone: 1 (813) 817 2042
About Protean BioDiagnostics
Protean is an innovative diagnostic company developing new approaches to improving precision medicine including inventing digital pathology tools to improve cancer screening and detection.
Protean MAPS™ is the only unique precision medicine system that provides easy access to advanced comprehensive laboratory diagnostic tests and easy to understand reports along with telemedicine support. Protean’s mission is to accelerate and bring optimized precision care to all cancer patients regardless of where they live.
About Spesana
Spesana has developed a healthcare platform for all therapeutic areas in all settings of care to increase the velocity of patients moving to the right specialists with a unified medical record. Important to the mission is the focus on precision medicine, notably molecular diagnostics, and clinical collaborations to allow physicians, patients, and insurance teams to come together around the best available therapies and new clinical trials for patients. The company was founded by oncology information technology trailblazer Carla Balch and an experienced team known for building the first certified electronic medical record platform in oncology. Spesana creates real-time collaborations, decision support based on real-world data and molecular diagnostics results.
To learn more, visit www.spesana.com